Higher serum uric acid on admission is associated with higher short-term mortality and poorer long-term survival after myocardial infarction: Retrospective prognostic study

Croatian Medical Journal

Volumn 50, Issue 6, 2009, Pages 559-566

  Car, Siniša ^a   Trkulja, Vladimir ^b  

^a Varazdin General Hospital   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CREATINE KINASE; CREATININE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; STREPTOKINASE; TRIACYLGLYCEROL; URIC ACID;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; CROATIA; FEMALE; HAZARD RATIO; HOSPITAL ADMISSION; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL TIME; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CREATININE; CROATIA; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; POISSON DISTRIBUTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK; SURVIVAL ANALYSIS; URIC ACID;

EID: 75649129688     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2009.50.559     Document Type: Article

References (17)

1. Coleman LA, Roubenoff R. Gout. In: Caballero B, Allen L, Prentice A, editors. Encyclopedia of human nutrition, 2nd edition. Oxford (UK): Elsevier; 2005; p. 419-23.
2. Vitart V, Rudan I, Hayward C, Gray NK, Floyd J, Palmer CN, et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet. 2008;40:437-42. Medline:18327257 doi:10.1038/ng.106.
3. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359:1811-21. Medline:18946066 doi:10.1056/NEJMra0800885.
4. Tomita M, Mizuno S, Yokota K. Increased levels of serum uric acid among ex-smokers. J Epidemiol. 2008;18:132-4. Medline:18469491 doi:10.2188/jea. JE2006332.
5. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003;41:1183-90. Medline:12707287 doi:10.1161/01.HYP.0000069700.62727.C5. (Pubitemid 36706063)
6. Gagliardi AC, Miname MH, Santos RD. Uric acid: A marker of increased cardiovascular risk. Atherosclerosis. 2009;202:11-7. Medline:18585721 doi:10.1016/j.atherosclerosis.2008.05.022.
7. M ilionis HJ, Kalantzi KJ, Goudevenos JA, Seferiadis K, Mikhailidis DP, Elisaf MS. Serum uric acid levels and risk for acute ischaemic non-embolic stroke in elderly subjects. J Intern Med. 2005;258:435-41. Medline:16238679 doi:10.1111/j.1365-2796.2005.01565.x. (Pubitemid 41546559)
8. Weir CJ, Muir SW, Walters MR, Lees KR. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke. 2003;34:1951-6. Medline:12843346 doi:10.1161/01.STR.0000081983.34771.D2. (Pubitemid 36944787)
9. Karagiannis A, Mikhailidis DP, Tziomalos K, Sileli M, Savvatianos S, Kakafika A, et al. Serum uric acid as an independent predictor of early death after acute stroke. Circ J. 2007;71:1120-7. Medline:17587721 doi:10.1253/circj.71.1120. (Pubitemid 46998030)
10. Allison TG. Coronary heart disease epidemiology. In: Murphy JG, Lloyd MA, editors. Mayo clinic cardiology. 3rd edition. Rochester (MN): Mayo Clinic Scientific Press; 2007. p. 687-93.
11. Brodov Y, Chouraqui P, Goldenberg I, Boyko V, Mandelzweig L, Behar S. Serum uric acid for risk stratification of patients with coronary artery disease. Cardiology. 2009;114:300-5. Medline:19776568 doi:10.1159/000239860.
12. Dunkelgrun M, Welten GM, Goei D, Winkel TA, Schouten O, van Domburg RT, et al. Association between serum uric acid and perioperative and late cardiovascular outcome in patients with suspected or definite coronary artery disease undergoing elective vascular surgery. Am J Cardiol. 2008;102:797-801. Medline:18805100 doi:10.1016/j.amjcard.2008.05.019.
13. Kojima S, Sakamoto T, Ishihara M, Kimura K, Miyazaki S, Yamagishi M, et al. Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study). Am J Cardiol. 2005;96:489-95. Medline:16098298 doi:10.1016/j.amjcard.2005.04.007. (Pubitemid 41132762)
14. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159:702-6. Medline:15033648 doi:10.1093/aje/kwh090. (Pubitemid 38405384)
15. White HD, Chew DP. Acute myocardial infarction. Lancet. 2008;372:570-84. Medline:18707987 doi:10.1016/S0140- 6736(08)61237-4.
16. Wong CK, Stewart RA, Gao W, French JK, Raffel C, White HD. Prognostic differences between different types of bundle branch block during the early phase of acute myocardial infarction: insights from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial. Eur Heart J. 2006;27:21-8. Medline:16269419 doi:10.1093/eurheartj/ehi622. (Pubitemid 41785928)
17. Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology, Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29:2388-442. Medline:18799522 doi:10.1093/eurheartj/ehn309.